Consequently, chemerin’s regulatory role in energy balance and lipid storage highlights its potential as both a biomarker and a therapeutic target for managing metabolic syndrome and reducing cancer risk associated with metabolic disorders. This evidence concerns the gene RARRES2 and metabolic syndrome.